Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tutogen Will Launch Hernia Repair Product To Make Up For Urology Losses

This article was originally published in The Gray Sheet

Executive Summary

Tutogen will enter the $165 mil. hernia repair market by mid-2006 with a tissue-based product to offset declining urology sales

You may also be interested in...



Tutogen Turns A Profit For Fourth Consecutive Quarter, Plans ’08 Launches

Tutogen, a Florida company that provides surgeons with grafts made from human and animal tissues, announced it will launch new dental and hernia repair products in the U.S. next year

Tutogen Turns A Profit For Fourth Consecutive Quarter, Plans ’08 Launches

Tutogen, a Florida company that provides surgeons with grafts made from human and animal tissues, announced it will launch new dental and hernia repair products in the U.S. next year

People In Brief

Orthofix names new CEO: Chief Operating Officer Alan Milinazzo will be promoted to the orthopedic firm's top spot effective April 1. He will replace Charles Federico, who will remain a director of Orthofix. The company has not yet named a successor to the COO position. Milinazzo joined Orthofix as its first-ever operations executive in September 2005 after three years at Medtronic, where he served as VP of its vascular, peripheral and coronary business units. He previously worked at Boston Scientific for 12 years in a variety of roles, including VP of marketing. In January, the firm hired a new general manager for their vascular business (1"The Gray Sheet" Jan. 2, 2006, p. 19)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023070

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel